Drug Report History

Return to report

Below you will find the report version history. When a report is updated, a new version of the report is created. The report history allows you to see the changes between versions. You can select two versions of the report to compare. The fields that were changed between versions will be highlighted in yellow.

The translation of reports creates two separate versions which is why some reports may not seem to have any differences. In this case, only the language field below will be highlighted in yellow.

Version v7-EN Version v2-FR
Language English French
Date Updated 2017-10-28 2017-10-27
Drug Identification Number 02248129 02248129
Brand name AXERT 12.5MG AXERT 12.5MG
Common or Proper name AXERT AXERT
Company Name MCNEIL CONSUMER HEALTHCARE DIVISION OF JOHNSON & JOHNSON INC MCNEIL CONSUMER HEALTHCARE DIVISION OF JOHNSON & JOHNSON INC
Ingredients ALMOTRIPTAN ALMOTRIPTAN
Strength(s) 12.5MG 12.5MG
Dosage form(s) TABLET TABLET
Route of administration ORAL ORAL
Packaging size 6 TABLETS 6 TABLETS
ATC code N02CC N02CC
ATC description ANTIMIGRAINE PREPARATIONS ANTIMIGRAINE PREPARATIONS
Reason for discontinuation Business reasons Business reasons
Anticipated discontinuation date 2017-10-27 2017-10-27
Actual discontinuation date 2017-10-27 2017-10-27
Remaining supply date 2017-10-27 2017-10-27
Discontinuation status Discontinued To be discontinued
Discontinuation decision reversal no no
Tier 3 Status No No
Information on remaining supply
Company comments J&J North American to exit business. J&J North American to exit business.
Health Canada comments